← Back to catalogue

Thc Control 2

FDA UDI

Class I (US FDA UDI)

by Randox Laboratories, Ltd.

Identity

Trade Name
THC CONTROL 2 FDA UDI
Generic Name
Cannabinoid/cannabinoid metabolite IVD, control FDA UDI
Device Name
The Randox Cannabinoid Control - Level 2 is intended for use in the Quality Control of the 11-nor-Δ9-THC-9-COOH (Cannabinoid) assay. The Cannabinoid Control Level 2 contains the specific drug Cannabinoid. FDA UDI
Model / Reference
DA3128 FDA UDI
Description
The Randox Cannabinoid Control - Level 2 is intended for use in the Quality Control of the 11-nor-Δ9-THC-9-COOH (Cannabinoid) assay. The Cannabinoid Control Level 2 contains the specific drug Cannabinoid. FDA UDI

Identifiers

Catalog Number
DA3128 FDA UDI
Primary DI / UDI-DI
05055273207965 FDA UDI
510(k) Number
K092269 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
Cannabinoid/cannabinoid metabolite IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cannabinoid/cannabinoid metabolite IVD, control

Thc Control 2 by Randox Laboratories, Ltd. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cannabinoid/cannabinoid metabolite IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 4cc49efb-c888-45f3-b7f3-7da1011aa82f 37 fields · synced May 30, 2026